Introduction
Juvenile psammomatoid ossifying fibroma (JPOF) is an uncommon benign and locally aggressive tumor. It is a neoplasm composed of the stroma containing small ossicles resembling psammoma bodies [1].
The lesion occurs in the craniofacial bones of young adults, especially in the periorbital frontal and ethmoid ones [1]. JPOF continues to grow when left untreated [1]. Recurrence is usually due to incomplete removal, therefore, it is recommended to resect it completely [2].
The aim of this work is to report the clinical and histologic details of an extensive and locally aggressive JPOF involving the nasal cavity, sphenoid and ethmoid sinus with extention into the anterior cranial fossa.
Case report
An 18-year-old, healthy female, with the history of hyperpituitarism in 2004 and subsequent adenoidectomy in 2006, was consulted in University Clinical Center in Gdansk with three-day-lasting headache and repetitive oral bleeding in June and August 2015.
Computed tomography revealed a large, well-circumscribed, expansile mass occupying ethmoid cells, nasal cavities and ventral part of the sphenoid sinus. Additionally, the lesion extended into the anterior cranial fossa. In subsequent magnetic resonance imaging (MRI) the lesion presented as a polycystic tumor with fluid-fluid levels. On T1-weighted images, the non-cystic areas had intermediate signal intensity with enhancement after contrast medium administration. The lesion obstructed the sphenoid sinus causing mucocele (Fig. 1). An aneurysmal bone cyst (ABC) was suspected.
Pterional craniotomy was carried out and the tumour was removed incompletely. On microscopic examination the lesion was cellular with bland, monomorphic spindled cells dispersed in the stroma which contained numerous, small, round bony psammoma-like bodies. The stromal cells were negative for EMA, CD34, S100, PR, CK AE1/3. Cystic degeneration with ABC-like structures was observed. These cysts were lined by fibrous wall with giant cells and haemorrhages (Fig. 2). Final diagnosis of JPOF was rendered.
On one-year follow-up recurrence of the lesion was identified (Fig. 3). Therefore, the second surgery was performed, but the resection was incomplete. The lesion did not show any histological signs of malignancy. No further treatment was applied.
Discussion
The term ossifying fibroma (OF) is used to describe a benign, but potentially aggressive, bone-producing fibrous neoplasm of the craniofacial skeleton [3].
The current WHO classification distinguishes three similar histological variants of OF: cemento-ossifying fibroma (COF), juvenile trabecular ossifying fibroma (JTOF) and JPOF [1]. They were believed to have odontogenic origin [1], however, the recent research suggested JPOF and JTOF are nonodonto-
geniclesion [2].
COF is mainly seen in young adults. The onset of JTOF and JPOF is usually in childhood and adolescence [2, 4]. This is in accordance with our case of an 18-year-old girl.
COF is generally localized in the mandible with predilection to premolar and molar areas. Its growth is slow, with lingual and buccal expansion. Displacement of teeth is observed as the lesion expands [2, 5].
JTOF is mostly seen in the mandible and maxilla, affects predominantly the non-dental areas and grows rapidly [2]. JPOF occurs in paranasal sinuses, particularly in the frontal and ethmoid, but the lesion was also reported in the calvarium and the mandible [6]. It may penetrate the orbit and anterior cranial fossa. The bony expansion is the most common clinical manifestation. It can show various symptoms, e.g. proptosis, nasal obstruction, headaches, facial swelling,
pain and recurrent sinusitis [5]. It may also have an aggressive course [7].Our case developed in the nasal cavity and ethmoid sinus with extension into the anterior cranial fossa and affected also the sphenoid sinus, the site which has not been reported yet.
COF is composed of fibrous tissue that varies from intensely cellular to acellular areas. Examination reveals presence of a cementum-like material, blood vessels, woven and lamellar bone [2, 5]. JTOF comprises of bands of cell-rich osteoid encasing osteocytes and highly cellular fibrous stroma surrounded by slender trabeculae. JPOF is characterized by fibroblastic stroma containing spherical calcifications resembling psammoma bodies. The stroma varies from being hipercellular (usually) to fibroblastic and loose in texture [1, 2]. Cystic degeneration and aneurysmal bone cyst-like formation are commonly observed [8, 9].
These cysts are composed of thin fibrous wall and usually comprise osteoclast giant cells and haemorrhages [2], similarly to our case.
On radiographs, COF is well demarcated with variable radioopacity. Radiological imaging of JTOF and JPOF shows a well circumscribed lesion, its area may be radiolucent or radiopaque depending on the soft and hard tissue components [2, 9].
Apart from other fibro-osseous lesions, JPOF has to be distinguished from fibrous dysplasia, osteoblastoma, osteosarcoma, primary aneurysmal bone cyst. Intraosseous cavernous hemangioma and eosinophilic granuloma should also be taken into account due to radiologic and histologic similarities [10, 11]. JPOF may be misdiagnosed as extracranial menigioma with psammoma bodies, which is EMA positive, in contrast to JPOF [12]. JPOF is negative for S100 and CD34 [12], Our case is EMA, S100 and CD 34 negative.
A successful treatment of these craniofacial tumors is frequently problematic [13]. Recurrence is usually due to tumor persistence after incomplete removal and its rate ranges from 30 to 56% [8]. Enucleation and curettage may be succesful treatment for small JPOF, the larger and more aggressive tumours require resection with 5 mm margin [12]. Due to the tumor location, it would have to be removed down to the level of unchanged bone with preservation of contiguous vital structures as far as possible [12]. The location and extent of the tumor determine surgical approach(intracranial or a combined subfrontal and nasal) [14]. Endoscopic resection may be successful in some endonasal cases [15]. It is believed the lesion is radio-resistant, therefore, radiotherapy is contraindicated [16]. Some data proved the alpha-interferon therapy in combination with surgical curettage is an alternative treatment [13]. Clinical and radiological follow-up is requisite for JPOF. Malignant transformation was not reported in the literature [8]. In conclusion, the prognosis remains unfavorable in our case due to tumour location and its aggressive potential.
References
1. El-Naggar AK, Chan JKC, Grandis JR, et al. WHO classification of head and neck tumours. IARC, Lyon 2017; 251-252.
2.
Zegalie N, Speight PM, Martin L. Ossifying fibromas of the jaws and craniofacial bones. Diagnostic Histopathology 2015; 21: 351-358.
3.
Rinaggio J, Land M, Cleveland DB. Juvenile ossifying fibroma of the mandible. J Pediatr Surg 2003; 38: 648-650.
4.
Han J, Hu L, Zhang C, et al. Juvenile ossifying fibroma of the jaw: a retrospective study of 15 cases. Int J Oral Maxillofac Surg 2016; 45: 368-376.
5.
Wenig BM, Vinh TN, Smirniotopoulos JG, et al. Aggressive psammomatoid ossifying fibromas of the sinonasal region: a clinicopathologic study of a distinct group of fibro-osseous lesions. Cancer1995; 76: 1155-1165.
6.
Yadav N, Gupta P, Naik SR, Aggarwal A. Juvenile psammomatoid ossifying fibroma: An unusual case report. Contemp Clin Dent 2013; 4: 566-568.
7.
Brademann G, Werner JA, Jänig U, et al. Cemento-ossifying fibroma of the petromastoid region: case report and review of the literature. J Laryngol Otol 1997; 111: 152-155.
8.
El-Mofty S. Psammomatoid and trabecular juvenile ossifying fibroma of the craniofacial skeleton: two distinct clinicopathologic entities. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 296-304.
9.
Su L, Weathers DR, Waldron CA. Distinguishing features of focal cemento-osseous dysplasias and cemento-ossifying fibromas: I. A pathologic spectrum of 316 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 84: 301-309.
10.
Nakajima R, Saito N, Uchino A, et al. Juvenile psammomatoid ossifying fibroma with visual disturbance: a case report with imaging features. J Neuroimaging 2013; 23: 137-140.
11.
Barrena López C, BollarZabala A, ÚrculoBare¼o E. Cranial juvenile psammomatoid ossifying fibroma: case report. J Neurosurg Pediatr 2016; 17: 318-323.
12.
Sarode SC, Sarode GS, Waknis P, et al. Juvenile psammomatoid ossifying fibroma: a review. Oral Oncol 2011; 47: 1110-1116.
13.
Kelly PR. Interferon Alpha Therapy for Aggressive Juvenile Ossifying Fibroma. The American Association of Oral and Maxillofacial Surgeons, Scientific Poster Session 2008: 76-77.
14.
Lund VJ, Howard DJ, Wei WI, et al. Craniofacial resection for tumors of the nasal cavity and paranasal sinuses – a 17-year experience. Head Neck 1998; 20: 97-105.
15.
Liu JK, Mendelson ZS, Dubal PM, et al. The modified hemi-Lothrop procedure: a variation of the endoscopic endonasal approach for resection of a supraorbital psammomatoid ossifying fibroma. J Clin Neurosci 2014; 21: 2233-2238.
16.
Brademann G, Werner JA, Jänig U, et al. Cemento-ossifying fibroma of the petromastoid region: case report and review of the literature. J Laryngol Otol 1997; 111: 152-155.